Guru Ownership Trend
Guru Analysis for Crescent Biopharma, Inc. (CBIO)
Crescent Biopharma, Inc. (CBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.17 M.
Top institutional holders include Steven Cohen and Louis Moore Bacon.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $445,693 net outflow during the quarter.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Crescent Biopharma, Inc. (CBIO)
Major holders include Steven Cohen ($5.4 M), Louis Moore Bacon ($450,000). According to the latest reported data, 2 tracked investment managers collectively hold approximately 325,000 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $445,693, with 0 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CBIO. The total reported sell value was $445,693.
No tracked managers opened new positions or increased their holdings in CBIO during the most recent reporting period.